Past Events

Introduction to Innovation in Medical Evidence and Development Surveillance (IMEDS): The Research Resource

On October 30, 2024, we held a one-hour session on IMEDS, a flagship program of the Regan-Udall Foundation for the FDA.

Biosimilar Roundtables

The Reagan-Udall Foundation for the FDA conducted a series of five closed-door virtual roundtable conversations with biosimilar developers to explore emerging areas of regulatory science and to create a space for active discussion and exploration between FDA and biosimilar developers.

LDT Industry Education: Record Keeping and Adverse Event Reporting

Record Keeping and Adverse Event Reporting: Medical Device Reporting, Corrections and Removals and Quality System Complaint Requirements LDT Industry Education

Advancing Rare Disease Therapies Through an FDA Rare Disease Innovation Hub

The Reagan-Udall Foundation for the FDA, in collaboration with FDA’s Rare Disease Innovation Hub, hosted a public meeting on October 16, 2024.

Virtual Public Meeting on FDA's Final Rule on Requirements for Additional Traceability Records for Certain Foods

On October 7, we hosted a virtual public meeting to hear insights on the Final Rule on Requirements for Additional Traceability Records from both FDA leadership and other experts from across food industry sectors.

Advancing Treatments for Post-Traumatic Stress Disorder

The Reagan-Udall Foundation for the FDA, in support of FDA’s ongoing focus on PTSD, convened “Advancing Treatments for Post-Traumatic Stress Disorder,” a public meeting with stakeholder comment.

Scientific Advancements in Gene Therapies: Opportunities for Global Regulatory Convergence

The Reagan-Udall Foundation for the FDA, in collaboration with the Bill & Melinda Gates Foundation, will host a hybrid public workshop on "Scientific Advancements in Gene Therapies: Opportunities for Global Regulatory Convergence."
-

Online Controlled Substances Summit

The Food and Drug Administration (FDA) and the Reagan-Udall Foundation for the FDA convened the fifth Online Controlled Substances Summit.

Implementing the RAISE Action Framework

Implementing the RAISE Action Framework Webinar July 16, 2024 | 2-3pm (eastern)  

Understanding Current Use of Ketamine for Emerging Areas of Therapeutic Interest

The Reagan-Udall Foundation for the FDA, in collaboration with the FDA, hosted a hybrid public workshop on "Understanding Current Use of Ketamine for Emerging Areas of Therapeutic Interest."